You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
魯抗醫藥(600789.SH):頭孢呋辛酯幹混懸劑通過一致性評價

格隆匯8月13日丨魯抗醫藥(600789.SH)公佈,公司收到國家藥品監督管理局頒發的關於頭孢呋辛酯幹混懸劑(以下簡稱“該藥品”)的《藥品補充申請批準通知書》(證書編號:2025B02754),該藥品通過仿製藥質量和療效一致性評價。

頭孢呋辛酯爲頭孢呋辛的前體藥,屬於第二代頭孢菌素類抗生素,作用機制爲抑制細菌細胞壁合成,使細菌不能繁殖。本品具有廣譜抗菌作用,對化膿性鏈球菌、肺炎球菌、葡萄球菌、甲氧西林敏感株、卡他莫拉菌、淋球菌、流感嗜血桿菌等有強大抗菌作用,對大腸桿菌、肺炎克雷伯菌、變形桿菌屬等腸桿菌科細菌亦有良好作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account